Steve Miller - 21 Nov 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Operating Officer
Signature
/s/ Steve Miller
Issuer symbol
CPRX
Transactions as of
21 Nov 2022
Net transactions value
-$1,568,820
Form type
4
Filing time
23 Nov 2022, 16:01:05 UTC
Previous filing
15 Sep 2022
Next filing
08 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Sale $1,222,080 -80,000 -12% $15.28 573,791 21 Nov 2022 Direct F1, F2
transaction CPRX Common stock, par value $0.001 per share Sale $346,740 -20,000 -3.5% $17.34 553,791 23 Nov 2022 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold for personal reasons. Shares were not sold as a result of any disagreement with the Company and Dr. Miller remains an officer of the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.07 to $15.52 per share.
F3 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $17.12 to $17.70 per share.